v3.26.1
STOCKHOLDERS’ EQUITY (Tables)
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
SCHEDULE OF CHANGE IN THE ACCRUED PREFERRED STOCK REDEMPTION PAYABLE

As of December 31, 2025, the following table sets forth a summary of the change in the accrued preferred stock redemption payable (H-7):

 

   Accrued preferred stock redemption payable (H-7) 
Beginning balance at January 1, 2024  $- 
New redemptions and cash premiums   11,484,609 
Cash payments   (10,198,929)
Ending balance at December 31, 2024  $1,285,680 
New redemptions and cash premiums   11,555,021 
Waiver consideration   350,000 
August 4th Amendment   (5,309,174)
Cash payments   (7,881,527)
Ending balance at December 31, 2025  $— 
SCHEDULE OF WARRANT ACTIVITY

A summary of the Company’s warrants to purchase common stock activity is as follows:

 

   Shares Underlying Warrants   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term (in years) 
Outstanding at December 31, 2024   722,761   $51.04    3.44 
Granted   4,928,427    6.66    — 
Exercised   (178,200)   6.19    — 
Expired   (19,112)  $964,48    — 
Outstanding at December 31, 2025   5,453,876   $7.35    3.00